HIV Citation List: January 30 - February 12, 2015

PubMed Citations

1. A Novel Ribonuclease with HIV-1 Reverse Transcriptase Inhibitory Activity Purified from the Fungus Ramaria formosa. Zhang, R., G. Tian, Y. Zhao, L. Zhao, H. Wang, Z. Gong, and T.B. Ng. Journal of Basic Microbiology, 2015. 55(2): p. 269-275. PMID[24523258].
[PubMed]. HIV_0130-021215.

2. Synthesis and Biological Evaluation of DAPY-DPEs Hybrids as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Wu, H.Q., J. Yao, Q.Q. He, W.X. Chen, F.E. Chen, C. Pannecouque, E. De Clercq, and D. Daelemans. Bioorganic & Medicinal Chemistry, 2015. 23(3): p. 624-631. PMID[25537532].
[PubMed]. HIV_0130-021215.

3. An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor. Wang, H., M.D. Kowalski, A.S. Lakdawala, F.G. Vogt, and L. Wu. Organic Letters, 2015. 17(3): p. 564-567. PMID[25615910].
[PubMed]. HIV_0130-021215.

4. Synthesis and Evaluation of C2-Carbon-linked Heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 Integrase Inhibitors. Naidu, B.N., M.E. Sorenson, M. Patel, Y. Ueda, J. Banville, F. Beaulieu, S. Bollini, I.B. Dicker, H. Higley, Z. Lin, L. Pajor, D.D. Parker, B.J. Terry, M. Zheng, A. Martel, N.A. Meanwell, M. Krystal, and M.A. Walker. Bioorganic & Medicinal Chemistry Letters, 2015. 25(3): p. 717-720. PMID[25529736].
[PubMed]. HIV_0130-021215.

5. In Vivo Evaluation of Different Formulation Strategies for Sustained Release Injectables of a Poorly Soluble HIV Protease Inhibitor. Meeus, J., D.J. Scurr, K. Amssoms, K. Wuyts, P. Annaert, M.C. Davies, C.J. Roberts, and G. Van den Mooter. Journal of Controlled Release, 2015. 199: p. 1-9. PMID[25485732].
[PubMed]. HIV_0130-021215.

6. Synthesis of Novel 2',3'-Difluorinated 5'-Deoxythreosyl phosphonic acid Nucleosides as Antiviral Agents. Kim, E., S. Kim, and J.H. Hong. Nucleosides, Nucleotides & Nucleic Acids, 2015. 34(2): p. 130-147. PMID[25621706].
[PubMed]. HIV_0130-021215.

7. Enhancement and Induction of HIV-1 Infection through an Assembled Peptide Derived from the CD4 Binding Site of gp120. Gross, A., K. Rodel, B. Kneidl, N. Donhauser, M. Mossl, E. Lump, J. Munch, B. Schmidt, and J. Eichler. ChemBioChem, 2015. 16(3): p. 446-454. PMID[25639621].
[PubMed]. HIV_0130-021215.

8. Novel in Vitro Inhibitory Functions of Potato Tuber Proteinaceous Inhibitors. Fischer, M., M. Kuckenberg, R. Kastilan, J. Muth, and C. Gebhardt. Molecular Genetics and Genomics, 2015. 290(1): p. 387-398. PMID[25260821].
[PubMed]. HIV_0130-021215.

9. Design, Synthesis, and Biological Evaluation of Unconventional Aminopyrimidine, Aminopurine, and Amino-1,3,5-triazine methyloxynucleosides. Fernandez-Cureses, G., S. de Castro, M.L. Jimeno, J. Balzarini, and M.J. Camarasa. ChemMedChem, 2015. 10(2): p. 321-335. PMID[25420933].
[PubMed]. HIV_0130-021215.

ISI Web of Knowledge Citations

10. Anti-HIV Activity of Vaginal Epithelial Cells and Vaginal Secretions. Patel, M.V., M. Ghosh, R.M. Rossoll, J.V. Fahey, and C.R. Wira. AIDS Research and Human Retroviruses, 2014. 30: p. A237-A237. ISI[000344774403062].

[WOS]. HIV_0130-021215.

11. Structural Modification of Diarylpyrimidine Derivatives as HIV-1 Reverse Transcriptase Inhibitors. Gu, S.X., Y.Y. Zhu, F.E. Chen, C.E. De, J. Balzarini, and C. Pannecouque. Medicinal Chemistry Research, 2015. 24(1): p. 220-225. ISI[000347405700019].

[WOS]. HIV_0130-021215.

12. HBAHP-25 Inhibits HIV-1 Entry into Cells and Neutralizes gp120 Induced Inflammation. Bashir, T., M. Patgaonkar, S. Kumar, and K.V.R. Reddy. AIDS Research and Human Retroviruses, 2014. 30: p. A49-A49. ISI[000344774400104].

[WOS]. HIV_0130-021215.

13. Design and Synthesis of N-Hydroxytriazole-4-carboxamides as HIV Integrase Inhibitors. Bai, Y.X., L.J. Li, X.L. Wang, C.C. Zeng, and L.M. Hu. Medicinal Chemistry Research, 2015. 24(1): p. 423-429. ISI[000347405700038].

[WOS]. HIV_0130-021215.

14. Glycolysis Inhibitors as Potential anti-HIV Compounds. Songok, E., B. Nzau, M. Wainberg, F. Plummer, and S. Mpoke. AIDS Research and Human Retroviruses, 2014. 30: p. A206-A207. ISI[000344774402161].

[WOS]. HIV_0130-021215.

15. Broad-spectrum anti-HIV-1 Activity of Anionic Carbosilane Dendrimers and Synergy in Combination with Maraviroc and Tenofovir as Topical Microbicide. Sepulveda-Crespo, D., M.J. Serramia, J. Sanchez-Rodriguez, R. Lorente, R. Gomez, F.J. de la Mata, J.L. Jimenez, and M.A. Munoz-Fernandez. AIDS Research and Human Retroviruses, 2014. 30: p. A144-A145. ISI[000344774401171].

[WOS]. HIV_0130-021215.

16. Antiviral Action of Sulfonate Anionic Carbosilane Dendrimer as a Topical Microbicide against HIV Infection. Sepulveda-Crepo, D., J. Sanchez-Rodriguez, M.J. Serramia, A. Lopez, E. Alonso, R. Gomez, F.J. de la Mata, J.L. Jimenez, and M.A. Munoz-Fernandez. AIDS Research and Human Retroviruses, 2014. 30: p. A205-A205. ISI[000344774402156].

[WOS]. HIV_0130-021215.

17. 2',3'-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication. Schachter, J., A.L.C. Valadao, R.S. Aguiar, V. Barreto-de-Souza, A.D. Rossi, P.R. Arantes, H. Verli, P.G. Quintana, N. Heise, A. Tanuri, D.C. Bou-Habib, and P.M. Persechini. Current HIV Research, 2014. 12(5): p. 347-358. ISI[000347469000005].

[WOS]. HIV_0130-021215.

18. Identification of a Novel Acylguanidine-based Inhibitor of HIV-1 Replication. Mwimanzi, P.M., I. Tietjen, A. Shahid, S.C. Miller, D. Fedida, Z. Brummer, and M. Brockman. AIDS Research and Human Retroviruses, 2014. 30: p. A205-A205. ISI[000344774402157].

[WOS]. HIV_0130-021215.

19. Reactivation of Latent HIV-1 by Bryostatin-1 in the Presence of Antiretroviral Drugs. Martinez-Bonet, M., M.I. Clemente, S. Alvarez, L. Diaz, D. Garcia-Alonso, A. Lopez, S. Moreno, E. Munoz, and M. Munoz-Fernandez. AIDS Research and Human Retroviruses, 2014. 30: p. A285-A285. ISI[000344774404014].

[WOS]. HIV_0130-021215.

20. Inhibiting HIV-1 with Chimeric tRNA-miRNA Mimics. Gao, E. and K. Haushalter. FASEB Journal, 2014. 28(1). ISI[000346646704112].

[WOS]. HIV_0130-021215.

21. Synthesis of Cholesterol Conjugated Non-native Derived Heptad Repeat Sequence Peptides as Potent HIV-1 Fusion Inhibitors. Zhang, S., W.G. Shi, C. Wang, L.F. Cai, B.H. Zheng, K. Wang, S.L. Feng, Q.Y. Jia, and K.L. Liu. Chemical Journal of Chinese Universities-Chinese, 2014. 35(12): p. 2542-2546. ISI[000347669400008].

[WOS]. HIV_0130-021215.

22. In Vitro Reactivation of Latent HIV-1 by Cytostatic bis (Thiosemicarbazonate) gold(III) Complexes. Fonteh, P. and D. Meyer. BMC Infectious Diseases, 2014. 14. ISI[000348275600001].

[WOS]. HIV_0130-021215.

23. Synthesis of Novel p-tert-Butylcalix[4]arene Schiff Bases and Their Complexes with C60, Potential HIV-protease Inhibitors. Khadra, K.A., S. Mizyed, D. Marji, S.F. Haddad, M. Ashram, and A. Foudeh. Spectrochimica Acta Part A-Molecular and Biomolecular Spectroscopy, 2015. 136: p. 1869-1874. ISI[000347583300079].

[WOS]. HIV_0130-021215.